Rubicon Research Limited (BOM:544578)
India · Delayed Price · Currency is INR 1,492.60
-3.10 (-0.21%)
At close: Jul 31, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 245.64 billion as of July 31, 2026.
Market Cap
245.64B
Enterprise Value
245.29B
Revenue
17.54B
Ranking
n/a
PE Ratio
99.56
Stock Price
1,492.60
ChartMarket Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 245.64B, an increase of 137.34%. That is a compound annual growth rate of 199.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 245.64B | 119.02% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 585.76B |
| GlaxoSmithKline Pharmaceuticals | 442.09B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 247.16B |
| Granules India | 206.66B |
| AstraZeneca Pharma India | 202.25B |
| Caplin Point Laboratories | 192.62B |
| Jubilant Pharmova | 152.25B |